Joe G. N. Garcia

Aqualung Therapeutics Corp.

NIH Rank #2558
  • Program Leader
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,558
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3M across 4 grants · National rank #2558.

Top grants by award amount

Joe G. N. Garcia's NIH grant portfolio, ranked by award amount.

  • 5R42DK135208-03R42
    Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity
    $975.2K
    award amount
  • 5R44HL145930-05R44
    A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
    $957.6K
    award amount
  • 5R42HL164300-03R42
    Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
    $809K
    award amount
  • 5P01HL126609-08P01
    Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS
    $294.5K
    award amount

Affiliations

Institutions that have administered grants for Joe G. N. Garcia.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Aqualung Therapeutics Corp.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2558
  6. 2024
    Entered Top 25% Nationally
    Ranked #2558
  7. 2024
    Multi-Institutional Research
    Awards at 2 institutions